tiprankstipranks
Viking Therapeutics (VKTX)
NASDAQ:VKTX
US Market

Viking Therapeutics (VKTX) Income Statement

Compare
5,861 Followers

Viking Therapeutics Income Statement

Last quarter (Q4 2024), Viking Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Viking Therapeutics's net income was $-35.42M. See Viking Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -292.00K$ -291.00K$ -296.00K$ -277.00K
Operating Expenses
$ 150.92M$ 100.83M$ 70.36M$ 55.68M$ 42.66M
Depreciation and Amortization
$ 0.00$ 292.00K$ 291.00K$ 296.00K$ 277.00K
EBITDA
$ -150.92M$ -100.83M$ -70.36M$ -55.39M$ -42.66M
Operating Income
$ -150.92M$ -100.83M$ -70.36M$ -55.68M$ -42.66M
Other Income/Expenses
$ 40.96M$ 14.93M$ 1.49M$ 692.00K$ 3.17M
Pretax Income
$ -109.96M$ -85.89M$ -68.87M$ -54.99M$ -39.49M
Net Income
$ -109.96M$ -85.89M$ -67.38M$ -54.00M$ -36.05M
Per Share Metrics
Basic EPS
$ -1.01$ -0.91$ -0.88$ -0.70$ -0.50
Diluted EPS
$ -1.01$ -0.91$ -0.88$ -0.70$ -0.50
Weighted Average Shares Outstanding
109.04M 94.35M 76.83M 77.20M 72.60M
Weighted Average Shares Outstanding (Diluted)
109.04M 94.35M 76.83M 77.20M 72.60M
Currency in USD

Viking Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis